1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Monotherapy 1.2.3 Combination Therapy 1.3 Market by Application 1.3.1 Global Chimeric Antigen Receptor Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Acute Leukemia 1.3.3 Non-hodgkin's Lymphoma 1.3.4 Multiple Myeloma 1.3.5 Transplant Rejection 1.3.6 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Chimeric Antigen Receptor Cell Therapy Market Perspective (2016-2027) 2.2 Chimeric Antigen Receptor Cell Therapy Growth Trends by Regions 2.2.1 Chimeric Antigen Receptor Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Chimeric Antigen Receptor Cell Therapy Historic Market Share by Regions (2016-2021) 2.2.3 Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Regions (2022-2027) 2.3 Chimeric Antigen Receptor Cell Therapy Industry Dynamic 2.3.1 Chimeric Antigen Receptor Cell Therapy Market Trends 2.3.2 Chimeric Antigen Receptor Cell Therapy Market Drivers 2.3.3 Chimeric Antigen Receptor Cell Therapy Market Challenges 2.3.4 Chimeric Antigen Receptor Cell Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue 3.1.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue (2016-2021) 3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Players (2016-2021) 3.2 Global Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Chimeric Antigen Receptor Cell Therapy Revenue 3.4 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio 3.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor Cell Therapy Revenue in 2020 3.5 Chimeric Antigen Receptor Cell Therapy Key Players Head office and Area Served 3.6 Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service 3.7 Date of Enter into Chimeric Antigen Receptor Cell Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Chimeric Antigen Receptor Cell Therapy Breakdown Data by Type 4.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Type (2016-2021) 4.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Type (2022-2027) 5 Chimeric Antigen Receptor Cell Therapy Breakdown Data by Application 5.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Application (2016-2021) 5.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Chimeric Antigen Receptor Cell Therapy Market Size (2016-2027) 6.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type 6.2.1 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2021) 6.2.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2022-2027) 6.2.3 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2027) 6.3 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application 6.3.1 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2021) 6.3.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2022-2027) 6.3.3 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2027) 6.4 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country 6.4.1 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2016-2021) 6.4.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size (2016-2027) 7.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type 7.2.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2021) 7.2.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2022-2027) 7.2.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2027) 7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application 7.3.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2021) 7.3.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2022-2027) 7.3.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2027) 7.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country 7.4.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2016-2021) 7.4.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size (2016-2027) 8.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type 8.2.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2027) 8.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application 8.3.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2027) 8.4 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region 8.4.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size (2016-2027) 9.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type 9.2.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2021) 9.2.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2022-2027) 9.2.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2027) 9.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application 9.3.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2021) 9.3.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2022-2027) 9.3.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2027) 9.4 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country 9.4.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2016-2021) 9.4.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size (2016-2027) 10.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type 10.2.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2027) 10.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application 10.3.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2027) 10.4 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country 10.4.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Amgen Inc 11.1.1 Amgen Inc Company Details 11.1.2 Amgen Inc Business Overview 11.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Introduction 11.1.4 Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.1.5 Amgen Inc Recent Development 11.2 Autolus Therapeutics Plc 11.2.1 Autolus Therapeutics Plc Company Details 11.2.2 Autolus Therapeutics Plc Business Overview 11.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Introduction 11.2.4 Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.2.5 Autolus Therapeutics Plc Recent Development 11.3 Beijing Immunochina Medical Science & Technology Co Ltd 11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details 11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview 11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development 11.4 Bellicum Pharmaceuticals Inc 11.4.1 Bellicum Pharmaceuticals Inc Company Details 11.4.2 Bellicum Pharmaceuticals Inc Business Overview 11.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Introduction 11.4.4 Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.4.5 Bellicum Pharmaceuticals Inc Recent Development 11.5 Bristol-Myers Squibb Co 11.5.1 Bristol-Myers Squibb Co Company Details 11.5.2 Bristol-Myers Squibb Co Business Overview 11.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Introduction 11.5.4 Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.5.5 Bristol-Myers Squibb Co Recent Development 11.6 bluebird bio Inc 11.6.1 bluebird bio Inc Company Details 11.6.2 bluebird bio Inc Business Overview 11.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Introduction 11.6.4 bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.6.5 bluebird bio Inc Recent Development 11.7 CARsgen Therapeutics Ltd 11.7.1 CARsgen Therapeutics Ltd Company Details 11.7.2 CARsgen Therapeutics Ltd Business Overview 11.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Introduction 11.7.4 CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.7.5 CARsgen Therapeutics Ltd Recent Development 11.8 Celgene Corp 11.8.1 Celgene Corp Company Details 11.8.2 Celgene Corp Business Overview 11.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Introduction 11.8.4 Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.8.5 Celgene Corp Recent Development 11.9 Cell Medica Ltd 11.9.1 Cell Medica Ltd Company Details 11.9.2 Cell Medica Ltd Business Overview 11.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Introduction 11.9.4 Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.9.5 Cell Medica Ltd Recent Development 11.10 Cellular Biomedicine Group Inc 11.10.1 Cellular Biomedicine Group Inc Company Details 11.10.2 Cellular Biomedicine Group Inc Business Overview 11.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Introduction 11.10.4 Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.10.5 Cellular Biomedicine Group Inc Recent Development 11.11 Celularity Inc 11.11.1 Celularity Inc Company Details 11.11.2 Celularity Inc Business Overview 11.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Introduction 11.11.4 Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.11.5 Celularity Inc Recent Development 11.12 Celyad SA 11.12.1 Celyad SA Company Details 11.12.2 Celyad SA Business Overview 11.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Introduction 11.12.4 Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.12.5 Celyad SA Recent Development 11.13 Daiichi Sankyo Co Ltd 11.13.1 Daiichi Sankyo Co Ltd Company Details 11.13.2 Daiichi Sankyo Co Ltd Business Overview 11.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 11.13.4 Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.13.5 Daiichi Sankyo Co Ltd Recent Development 11.14 Fosun Pharmaceutical AG 11.14.1 Fosun Pharmaceutical AG Company Details 11.14.2 Fosun Pharmaceutical AG Business Overview 11.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Introduction 11.14.4 Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.14.5 Fosun Pharmaceutical AG Recent Development 11.15 Gilead Sciences Inc 11.15.1 Gilead Sciences Inc Company Details 11.15.2 Gilead Sciences Inc Business Overview 11.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Introduction 11.15.4 Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.15.5 Gilead Sciences Inc Recent Development 11.16 Guangzhou Anjie Biomedical Technology Co Ltd 11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details 11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview 11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development 11.17 Hangzhou Converd Co Ltd 11.17.1 Hangzhou Converd Co Ltd Company Details 11.17.2 Hangzhou Converd Co Ltd Business Overview 11.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 11.17.4 Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.17.5 Hangzhou Converd Co Ltd Recent Development 11.18 Hebei Senlang Biotechnology Inc Ltd 11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details 11.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview 11.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Introduction 11.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development 11.18 HRAIN Biotechnology Co Ltd 11.25.1 HRAIN Biotechnology Co Ltd Company Details 11.25.2 HRAIN Biotechnology Co Ltd Business Overview 11.25.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 11.25.4 HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.25.5 HRAIN Biotechnology Co Ltd Recent Development 11.20 Juno Therapeutics Inc 11.20.1 Juno Therapeutics Inc Company Details 11.20.2 Juno Therapeutics Inc Business Overview 11.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction 11.20.4 Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.20.5 Juno Therapeutics Inc Recent Development 11.21 Kite Pharma Inc 11.21.1 Kite Pharma Inc Company Details 11.21.2 Kite Pharma Inc Business Overview 11.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Introduction 11.21.4 Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.21.5 Kite Pharma Inc Recent Development 11.22 Nanjing Legend Biotech Co Ltd 11.22.1 Nanjing Legend Biotech Co Ltd Company Details 11.22.2 Nanjing Legend Biotech Co Ltd Business Overview 11.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 11.22.4 Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.22.5 Nanjing Legend Biotech Co Ltd Recent Development 11.23 NantKwest Inc 11.23.1 NantKwest Inc Company Details 11.23.2 NantKwest Inc Business Overview 11.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Introduction 11.23.4 NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.23.5 NantKwest Inc Recent Development 11.24 Nkarta Inc 11.24.1 Nkarta Inc Company Details 11.24.2 Nkarta Inc Business Overview 11.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Introduction 11.24.4 Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.24.5 Nkarta Inc Recent Development 11.25 Novartis AG 11.25.1 Novartis AG Company Details 11.25.2 Novartis AG Business Overview 11.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Introduction 11.25.4 Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.25.5 Novartis AG Recent Development 11.26 Ono Pharmaceutical Co Ltd 11.26.1 Ono Pharmaceutical Co Ltd Company Details 11.26.2 Ono Pharmaceutical Co Ltd Business Overview 11.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 11.26.4 Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.26.5 Ono Pharmaceutical Co Ltd Recent Development 11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd 11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details 11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview 11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction 11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development 11.28 Sorrento Therapeutics Inc 11.28.1 Sorrento Therapeutics Inc Company Details 11.28.2 Sorrento Therapeutics Inc Business Overview 11.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction 11.28.4 Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.28.5 Sorrento Therapeutics Inc Recent Development 11.29 Takara Bio Inc 11.29.1 Takara Bio Inc Company Details 11.29.2 Takara Bio Inc Business Overview 11.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Introduction 11.29.4 Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) 11.29.5 Takara Bio Inc Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Monotherapy Table 3. Key Players of Combination Therapy Table 4. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2016-2021) Table 8. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2022-2027) Table 10. Chimeric Antigen Receptor Cell Therapy Market Trends Table 11. Chimeric Antigen Receptor Cell Therapy Market Drivers Table 12. Chimeric Antigen Receptor Cell Therapy Market Challenges Table 13. Chimeric Antigen Receptor Cell Therapy Market Restraints Table 14. Global Chimeric Antigen Receptor Cell Therapy Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Chimeric Antigen Receptor Cell Therapy Market Share by Players (2016-2021) Table 16. Global Top Chimeric Antigen Receptor Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2020) Table 17. Ranking of Global Top Chimeric Antigen Receptor Cell Therapy Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Chimeric Antigen Receptor Cell Therapy Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service Table 21. Date of Enter into Chimeric Antigen Receptor Cell Therapy Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 24. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2016-2021) Table 25. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Chimeric Antigen Receptor Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Application (2016-2021) Table 29. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 32. North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 34. North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 61. Amgen Inc Company Details Table 62. Amgen Inc Business Overview Table 63. Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Table 64. Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 65. Amgen Inc Recent Development Table 66. Autolus Therapeutics Plc Company Details Table 67. Autolus Therapeutics Plc Business Overview Table 68. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Table 69. Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 70. Autolus Therapeutics Plc Recent Development Table 71. Beijing Immunochina Medical Science & Technology Co Ltd Company Details Table 72. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview Table 73. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 74. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 75. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development Table 76. Bellicum Pharmaceuticals Inc Company Details Table 77. Bellicum Pharmaceuticals Inc Business Overview Table 78. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Table 79. Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 80. Bellicum Pharmaceuticals Inc Recent Development Table 81. Bristol-Myers Squibb Co Company Details Table 82. Bristol-Myers Squibb Co Business Overview Table 83. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Table 84. Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 85. Bristol-Myers Squibb Co Recent Development Table 86. bluebird bio Inc Company Details Table 87. bluebird bio Inc Business Overview Table 88. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Table 89. bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 90. bluebird bio Inc Recent Development Table 91. CARsgen Therapeutics Ltd Company Details Table 92. CARsgen Therapeutics Ltd Business Overview Table 93. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Table 94. CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 95. CARsgen Therapeutics Ltd Recent Development Table 96. Celgene Corp Company Details Table 97. Celgene Corp Business Overview Table 98. Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 99. Celgene Corp Recent Development Table 100. Cell Medica Ltd Company Details Table 101. Cell Medica Ltd Business Overview Table 102. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Table 103. Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 104. Cell Medica Ltd Recent Development Table 105. Cellular Biomedicine Group Inc Company Details Table 106. Cellular Biomedicine Group Inc Business Overview Table 107. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Table 108. Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 109. Cellular Biomedicine Group Inc Recent Development Table 110. Celularity Inc Company Details Table 111. Celularity Inc Business Overview Table 112. Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Table 113. Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 114. Celularity Inc Recent Development Table 115. Celyad SA Company Details Table 116. Celyad SA Business Overview Table 117. Celyad SA Chimeric Antigen Receptor Cell Therapy Product Table 118. Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 119. Celyad SA Recent Development Table 120. Daiichi Sankyo Co Ltd Company Details Table 121. Daiichi Sankyo Co Ltd Business Overview Table 122. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 123. Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 124. Daiichi Sankyo Co Ltd Recent Development Table 125. Fosun Pharmaceutical AG Company Details Table 126. Fosun Pharmaceutical AG Business Overview Table 127. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Table 128. Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 129. Fosun Pharmaceutical AG Recent Development Table 130. Gilead Sciences Inc Company Details Table 131. Gilead Sciences Inc Business Overview Table 132. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Table 133. Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 134. Gilead Sciences Inc Recent Development Table 135. Guangzhou Anjie Biomedical Technology Co Ltd Company Details Table 136. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview Table 137. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 138. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 139. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development Table 140. Hangzhou Converd Co Ltd Company Details Table 141. Hangzhou Converd Co Ltd Business Overview Table 142. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 143. Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 144. Hangzhou Converd Co Ltd Recent Development Table 145. Hebei Senlang Biotechnology Inc Ltd Company Details Table 146. Hebei Senlang Biotechnology Inc Ltd Business Overview Table 147. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Table 148. Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 149. Hebei Senlang Biotechnology Inc Ltd Recent Development Table 150. HRAIN Biotechnology Co Ltd Company Details Table 151. HRAIN Biotechnology Co Ltd Business Overview Table 152. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 153. HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 154. HRAIN Biotechnology Co Ltd Recent Development Table 155. Juno Therapeutics Inc Company Details Table 156. Juno Therapeutics Inc Business Overview Table 157. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Table 158. Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 159. Juno Therapeutics Inc Recent Development Table 160. Kite Pharma Inc Company Details Table 161. Kite Pharma Inc Business Overview Table 162. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Table 163. Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 164. Kite Pharma Inc Recent Development Table 165. Nanjing Legend Biotech Co Ltd Company Details Table 166. Nanjing Legend Biotech Co Ltd Business Overview Table 167. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 168. Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 169. Nanjing Legend Biotech Co Ltd Recent Development Table 170. NantKwest Inc Company Details Table 171. NantKwest Inc Business Overview Table 172. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Table 173. NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 174. NantKwest Inc Recent Development Table 175. Nkarta Inc Company Details Table 176. Nkarta Inc Business Overview Table 177. Nkarta Inc Chimeric Antigen Receptor Cell TherapyProduct Table 178. Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 179. Nkarta Inc Recent Development Table 180. Novartis AG Company Details Table 181. Novartis AG Business Overview Table 182. Novartis AG Chimeric Antigen Receptor Cell Therapy Product Table 183. Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 184. Novartis AG Recent Development Table 185. Ono Pharmaceutical Co Ltd Company Details Table 186. Ono Pharmaceutical Co Ltd Business Overview Table 187. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 188. Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 189. Ono Pharmaceutical Co Ltd Recent Development Table 190. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details Table 191. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview Table 192. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Table 193. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 194. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development Table 195. Sorrento Therapeutics Inc Company Details Table 196. Sorrento Therapeutics Inc Business Overview Table 197. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Table 198. Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 199. Sorrento Therapeutics Inc Recent Development Table 200. Takara Bio Inc Company Details Table 201. Takara Bio Inc Business Overview Table 202. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Table 203. Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) & (US$ Million) Table 204. Takara Bio Inc Recent Development Table 205. Research Programs/Design for This Report Table 206. Key Data Information from Secondary Sources Table 207. Key Data Information from Primary Sources List of Figures Figure 1. Global Chimeric Antigen Receptor Cell Therapy Market Share by Type: 2020 VS 2027 Figure 2. Monotherapy Features Figure 3. Combination Therapy Features Figure 4. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application: 2020 VS 2027 Figure 5. Acute Leukemia Case Studies Figure 6. Non-hodgkin's Lymphoma Case Studies Figure 7. Multiple Myeloma Case Studies Figure 8. Transplant Rejection Case Studies Figure 9. Other Case Studies Figure 10. Chimeric Antigen Receptor Cell Therapy Report Years Considered Figure 11. Global Chimeric Antigen Receptor Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Chimeric Antigen Receptor Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions: 2020 VS 2027 Figure 14. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2022-2027) Figure 15. Global Chimeric Antigen Receptor Cell Therapy Market Share by Players in 2020 Figure 16. Global Top Chimeric Antigen Receptor Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor Cell Therapy Revenue in 2020 Figure 18. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2016-2021) Figure 19. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2022-2027) Figure 20. North America Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2016-2027) Figure 22. North America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2016-2027) Figure 23. North America Chimeric Antigen Receptor Cell Therapy Market Share by Country (2016-2027) Figure 24. United States Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Chimeric Antigen Receptor Cell Therapy Market Share by Type (2016-2027) Figure 28. Europe Chimeric Antigen Receptor Cell Therapy Market Share by Application (2016-2027) Figure 29. Europe Chimeric Antigen Receptor Cell Therapy Market Share by Country (2016-2027) Figure 30. Germany Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Share by Type (2016-2027) Figure 38. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Share by Application (2016-2027) Figure 39. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Share by Region (2016-2027) Figure 40. China Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2016-2027) Figure 48. Latin America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2016-2027) Figure 49. Latin America Chimeric Antigen Receptor Cell Therapy Market Share by Country (2016-2027) Figure 50. Mexico Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Share by Type (2016-2027) Figure 54. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Share by Application (2016-2027) Figure 55. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Share by Country (2016-2027) Figure 56. Turkey Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Amgen Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 60. Autolus Therapeutics Plc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 61. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 62. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 63. Bristol-Myers Squibb Co Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 64. bluebird bio Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 65. CARsgen Therapeutics Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 66. Celgene Corp Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 67. Cell Medica Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 68. Cellular Biomedicine Group Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 69. Celularity Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 70. Celyad SA Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 71. Daiichi Sankyo Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 72. Fosun Pharmaceutical AG Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 73. Gilead Sciences Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 74. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 75. Hangzhou Converd Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 76. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 77. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 78. Juno Therapeutics Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 79. Kite Pharma Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 80. Nanjing Legend Biotech Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 81. NantKwest Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 82. Nkarta Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 83. Novartis AG Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 84. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 85. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 86. Sorrento Therapeutics Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 87. Takara Bio Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2016-2021) Figure 88. Bottom-up and Top-down Approaches for This Report Figure 89. Data Triangulation Figure 90. Key Executives Interviewed

Amgen Inc Autolus Therapeutics Plc Beijing Immunochina Medical Science & Technology Co Ltd Bellicum Pharmaceuticals Inc Bristol-Myers Squibb Co bluebird bio Inc CARsgen Therapeutics Ltd Celgene Corp Cell Medica Ltd Cellular Biomedicine Group Inc Celularity Inc Celyad SA Daiichi Sankyo Co Ltd Fosun Pharmaceutical AG Gilead Sciences Inc Guangzhou Anjie Biomedical Technology Co Ltd Hangzhou Converd Co Ltd Hebei Senlang Biotechnology Inc Ltd HRAIN Biotechnology Co Ltd Juno Therapeutics Inc Kite Pharma Inc Nanjing Legend Biotech Co Ltd NantKwest Inc Nkarta Inc Novartis AG Ono Pharmaceutical Co Ltd Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Sorrento Therapeutics Inc Takara Bio Inc